The antiinflammatory activity of budesonide on human airway epithelial cells is lasting after removal of the drug from cultures

Federica Sabatini, Michela Silvestri, Lucia Scarso, Giancarlo Brazzola, Giovanni A. Rossi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Because of its ability to conjugate extensively with fatty acids within lung cells, it has been suggested that budesonide (Bud) may have a prolonged pharmacologic activity, related to retention of the drug in airway tissues. Using human bronchial epithelial cells (HBECs) as target cells, we evaluated whether Bud could have a long-lasting inhibitory effect on ICAM-1 expression and GM-CSF release. HBECs were cultured in Bud (10 μM) or in medium alone (Ctr) for 24 hr, then extensively washed (to remove Bud) and incubated for an additional 6, 12, or 24 hr with IFN-γ ICAM-1 expression and GM-CSF release were then measured by flow cytometric analysis. In Ctr HBECs, IFN-γ induced a time-dependent upregulation of ICAM-1 expression, significant at 6, 12, or 24 hr (p <0.05, each comparison), and an increase in GM-CSF release, significant at 24 hr (p <0.05). The inhibitory effects of Bud preexposure on IFN-γ-induced ICAM-1 expression and GM-CSF release were then compared with those of a continuous exposure to the drug during IFN-γ stimulation. Preexposure to Bud (1 and 10 μM) induced a significant inhibition of IFN-γ-induced ICAM-1 expression (p <0.05, each comparison), but lower than that observed in HBECs continuously exposed at the same Bud concentrations (p <0.01, each comparison). In contrast, the inhibition of GM-CSF release was similar in preexposed and in exposed HBECs and statistically significant only at the highest Bud concentration tested (p <0.05, each comparison). Thus, Bud is effective in vitro in inducing a downregulation lasting 24 hr of mechanisms involved in leukocyte recruitment.

Original languageEnglish
Pages (from-to)11-20
Number of pages10
JournalJournal of Asthma
Volume39
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Budesonide
Anti-Inflammatory Agents
Epithelial Cells
Intercellular Adhesion Molecule-1
Granulocyte-Macrophage Colony-Stimulating Factor
Pharmaceutical Preparations
Leukocytes
Up-Regulation
Fatty Acids
Down-Regulation
Lung

Keywords

  • Glucocorticosteroids
  • Granulocyte-macrophage colony-stimulating factor
  • Intercellular adhesion molecule-1
  • Interferon-γ

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

The antiinflammatory activity of budesonide on human airway epithelial cells is lasting after removal of the drug from cultures. / Sabatini, Federica; Silvestri, Michela; Scarso, Lucia; Brazzola, Giancarlo; Rossi, Giovanni A.

In: Journal of Asthma, Vol. 39, No. 1, 2002, p. 11-20.

Research output: Contribution to journalArticle

@article{e6170f33ac194ec59881656ea0df9a6f,
title = "The antiinflammatory activity of budesonide on human airway epithelial cells is lasting after removal of the drug from cultures",
abstract = "Because of its ability to conjugate extensively with fatty acids within lung cells, it has been suggested that budesonide (Bud) may have a prolonged pharmacologic activity, related to retention of the drug in airway tissues. Using human bronchial epithelial cells (HBECs) as target cells, we evaluated whether Bud could have a long-lasting inhibitory effect on ICAM-1 expression and GM-CSF release. HBECs were cultured in Bud (10 μM) or in medium alone (Ctr) for 24 hr, then extensively washed (to remove Bud) and incubated for an additional 6, 12, or 24 hr with IFN-γ ICAM-1 expression and GM-CSF release were then measured by flow cytometric analysis. In Ctr HBECs, IFN-γ induced a time-dependent upregulation of ICAM-1 expression, significant at 6, 12, or 24 hr (p <0.05, each comparison), and an increase in GM-CSF release, significant at 24 hr (p <0.05). The inhibitory effects of Bud preexposure on IFN-γ-induced ICAM-1 expression and GM-CSF release were then compared with those of a continuous exposure to the drug during IFN-γ stimulation. Preexposure to Bud (1 and 10 μM) induced a significant inhibition of IFN-γ-induced ICAM-1 expression (p <0.05, each comparison), but lower than that observed in HBECs continuously exposed at the same Bud concentrations (p <0.01, each comparison). In contrast, the inhibition of GM-CSF release was similar in preexposed and in exposed HBECs and statistically significant only at the highest Bud concentration tested (p <0.05, each comparison). Thus, Bud is effective in vitro in inducing a downregulation lasting 24 hr of mechanisms involved in leukocyte recruitment.",
keywords = "Glucocorticosteroids, Granulocyte-macrophage colony-stimulating factor, Intercellular adhesion molecule-1, Interferon-γ",
author = "Federica Sabatini and Michela Silvestri and Lucia Scarso and Giancarlo Brazzola and Rossi, {Giovanni A.}",
year = "2002",
doi = "10.1081/JAS-120000802",
language = "English",
volume = "39",
pages = "11--20",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - The antiinflammatory activity of budesonide on human airway epithelial cells is lasting after removal of the drug from cultures

AU - Sabatini, Federica

AU - Silvestri, Michela

AU - Scarso, Lucia

AU - Brazzola, Giancarlo

AU - Rossi, Giovanni A.

PY - 2002

Y1 - 2002

N2 - Because of its ability to conjugate extensively with fatty acids within lung cells, it has been suggested that budesonide (Bud) may have a prolonged pharmacologic activity, related to retention of the drug in airway tissues. Using human bronchial epithelial cells (HBECs) as target cells, we evaluated whether Bud could have a long-lasting inhibitory effect on ICAM-1 expression and GM-CSF release. HBECs were cultured in Bud (10 μM) or in medium alone (Ctr) for 24 hr, then extensively washed (to remove Bud) and incubated for an additional 6, 12, or 24 hr with IFN-γ ICAM-1 expression and GM-CSF release were then measured by flow cytometric analysis. In Ctr HBECs, IFN-γ induced a time-dependent upregulation of ICAM-1 expression, significant at 6, 12, or 24 hr (p <0.05, each comparison), and an increase in GM-CSF release, significant at 24 hr (p <0.05). The inhibitory effects of Bud preexposure on IFN-γ-induced ICAM-1 expression and GM-CSF release were then compared with those of a continuous exposure to the drug during IFN-γ stimulation. Preexposure to Bud (1 and 10 μM) induced a significant inhibition of IFN-γ-induced ICAM-1 expression (p <0.05, each comparison), but lower than that observed in HBECs continuously exposed at the same Bud concentrations (p <0.01, each comparison). In contrast, the inhibition of GM-CSF release was similar in preexposed and in exposed HBECs and statistically significant only at the highest Bud concentration tested (p <0.05, each comparison). Thus, Bud is effective in vitro in inducing a downregulation lasting 24 hr of mechanisms involved in leukocyte recruitment.

AB - Because of its ability to conjugate extensively with fatty acids within lung cells, it has been suggested that budesonide (Bud) may have a prolonged pharmacologic activity, related to retention of the drug in airway tissues. Using human bronchial epithelial cells (HBECs) as target cells, we evaluated whether Bud could have a long-lasting inhibitory effect on ICAM-1 expression and GM-CSF release. HBECs were cultured in Bud (10 μM) or in medium alone (Ctr) for 24 hr, then extensively washed (to remove Bud) and incubated for an additional 6, 12, or 24 hr with IFN-γ ICAM-1 expression and GM-CSF release were then measured by flow cytometric analysis. In Ctr HBECs, IFN-γ induced a time-dependent upregulation of ICAM-1 expression, significant at 6, 12, or 24 hr (p <0.05, each comparison), and an increase in GM-CSF release, significant at 24 hr (p <0.05). The inhibitory effects of Bud preexposure on IFN-γ-induced ICAM-1 expression and GM-CSF release were then compared with those of a continuous exposure to the drug during IFN-γ stimulation. Preexposure to Bud (1 and 10 μM) induced a significant inhibition of IFN-γ-induced ICAM-1 expression (p <0.05, each comparison), but lower than that observed in HBECs continuously exposed at the same Bud concentrations (p <0.01, each comparison). In contrast, the inhibition of GM-CSF release was similar in preexposed and in exposed HBECs and statistically significant only at the highest Bud concentration tested (p <0.05, each comparison). Thus, Bud is effective in vitro in inducing a downregulation lasting 24 hr of mechanisms involved in leukocyte recruitment.

KW - Glucocorticosteroids

KW - Granulocyte-macrophage colony-stimulating factor

KW - Intercellular adhesion molecule-1

KW - Interferon-γ

UR - http://www.scopus.com/inward/record.url?scp=0036189422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036189422&partnerID=8YFLogxK

U2 - 10.1081/JAS-120000802

DO - 10.1081/JAS-120000802

M3 - Article

C2 - 11883735

AN - SCOPUS:0036189422

VL - 39

SP - 11

EP - 20

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 1

ER -